NCT05795647View on ClinicalTrials.gov

The PENTO Protocol in Medication-related Osteonecrosis of the Jaw

PHASE2RecruitingINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

April 7, 2025

Study Completion Date

April 7, 2025

Conditions
Medication-related Osteonecrosis of the Jaw (MRONJ)
Interventions
DRUG

Pentoxifylline+Tocopherol

Treatment will consist of pentoxifylline LP 400 mg morning and evening, combined with tocopherol 500 mg morning and evening

Trial Locations (1)

87042

RECRUITING

Limoges university hospital, Limoges

All Listed Sponsors
lead

University Hospital, Limoges

OTHER